Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chakraborty, A."'
Autor:
Jaya Shukla, Devinder K. Dhawan, Rakhee Vatsa, Priya Bhusari, Sunil Kumar, Bhagwant Rai Mittal, Gurpreet Singh, Sudipta Chakraborty, Ashutosh Dash
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 30(5)
For the growth and spread of a tumor beyond 2 mm, angiogenesis plays a crucial role, and association of various integrins with angiogenesis is evidential. The aim of the study was radiolabeling of DOTA-chelated RGD (arginine-glycine-aspartic acid) pe
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 30(2)
Peptide receptor radionuclide therapy (PRRT) is a site-directed targeted therapeutic strategy that specifically uses radiolabeled peptides as biological targeting vectors designed to deliver cytotoxic levels of radiation dose to cancer cells, which o
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 28(1)
Cyclic RGD (Arg-Gly-Asp) peptides radiolabeled with (68)Ga have great potential for the early tumor detection and noninvasive monitoring of tumor metastasis and therapeutic response. Herein, the preparation of (68)Ga-labeled DOTA-E[c(RGDfK)](2) (DOTA
Autor:
Tapas Das, András Polyák, Sharmila Banerjee, Meera Venkatesh, Lajos Balogh, Pradip Chaudhari, Gyozoo Janoki, Sudipta Chakraborty, Haladhar Dev Sarma, M. R. A. Pillai, Domokos Máthé
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 23(2)
Designing ideal radiopharmaceuticals for use as bone pain palliatives require the use of a moderate energy beta() emitter as a radionuclide and a suitable polyaminophosphonic acid as a carrier molecule. Owing to its suitable decay characteristics [T(